vs
DUCOMMUN INC（DCO）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
DUCOMMUN INC的季度营收约是Ultragenyx Pharmaceutical Inc.的1.0倍（$215.8M vs $207.3M），DUCOMMUN INC净利率更高（3.4% vs -62.0%，领先65.5%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 9.4%），DUCOMMUN INC自由现金流更多（$-78.8M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 6.3%）
杜科蒙是一家全球性航空航天与国防制造企业，主要供应复杂结构部件、电子系统，提供专业工程服务，覆盖商用航空、军事国防、航天领域客户，交付适用于关键航空航天场景的高可靠性解决方案。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
DCO vs RARE — 直观对比
营收规模更大
DCO
是对方的1.0倍
$207.3M
营收增速更快
RARE
高出16.5%
9.4%
净利率更高
DCO
高出65.5%
-62.0%
自由现金流更多
DCO
多$22.0M
$-100.8M
两年增速更快
RARE
近两年复合增速
6.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $215.8M | $207.3M |
| 净利润 | $7.4M | $-128.6M |
| 毛利率 | 27.7% | — |
| 营业利润率 | 6.5% | -54.7% |
| 净利率 | 3.4% | -62.0% |
| 营收同比 | 9.4% | 25.9% |
| 净利润同比 | 9.9% | 3.5% |
| 每股收益（稀释后） | $0.52 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DCORARE
| Q4 25 | $215.8M | $207.3M | ||
| Q3 25 | $212.6M | $159.9M | ||
| Q2 25 | $202.3M | $166.5M | ||
| Q1 25 | $194.1M | $139.3M | ||
| Q4 24 | $197.3M | $164.6M | ||
| Q3 24 | $201.4M | $139.5M | ||
| Q2 24 | $197.0M | $147.0M | ||
| Q1 24 | $190.8M | $108.8M |
净利润DCORARE
| Q4 25 | $7.4M | $-128.6M | ||
| Q3 25 | $-64.4M | $-180.4M | ||
| Q2 25 | $12.6M | $-115.0M | ||
| Q1 25 | $10.5M | $-151.1M | ||
| Q4 24 | $6.8M | $-133.2M | ||
| Q3 24 | $10.1M | $-133.5M | ||
| Q2 24 | $7.7M | $-131.6M | ||
| Q1 24 | $6.8M | $-170.7M |
毛利率DCORARE
| Q4 25 | 27.7% | — | ||
| Q3 25 | 26.6% | — | ||
| Q2 25 | 26.6% | — | ||
| Q1 25 | 26.6% | — | ||
| Q4 24 | 23.5% | — | ||
| Q3 24 | 26.2% | — | ||
| Q2 24 | 26.0% | — | ||
| Q1 24 | 24.6% | — |
营业利润率DCORARE
| Q4 25 | 6.5% | -54.7% | ||
| Q3 25 | -37.7% | -106.9% | ||
| Q2 25 | 8.5% | -64.8% | ||
| Q1 25 | 8.5% | -102.6% | ||
| Q4 24 | 5.3% | -74.3% | ||
| Q3 24 | 7.6% | -94.6% | ||
| Q2 24 | 7.1% | -79.1% | ||
| Q1 24 | 6.6% | -151.9% |
净利率DCORARE
| Q4 25 | 3.4% | -62.0% | ||
| Q3 25 | -30.3% | -112.8% | ||
| Q2 25 | 6.2% | -69.0% | ||
| Q1 25 | 5.4% | -108.5% | ||
| Q4 24 | 3.4% | -80.9% | ||
| Q3 24 | 5.0% | -95.7% | ||
| Q2 24 | 3.9% | -89.5% | ||
| Q1 24 | 3.6% | -156.8% |
每股收益（稀释后）DCORARE
| Q4 25 | $0.52 | $-1.28 | ||
| Q3 25 | $-4.30 | $-1.81 | ||
| Q2 25 | $0.82 | $-1.17 | ||
| Q1 25 | $0.69 | $-1.57 | ||
| Q4 24 | $0.45 | $-1.34 | ||
| Q3 24 | $0.67 | $-1.40 | ||
| Q2 24 | $0.52 | $-1.52 | ||
| Q1 24 | $0.46 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $45.3M | $421.0M |
| 总债务越低越好 | $298.8M | — |
| 股东权益账面价值 | $662.1M | $-80.0M |
| 总资产 | $1.2B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.45× | — |
8季度趋势，按日历期对齐
现金及短期投资DCORARE
| Q4 25 | $45.3M | $421.0M | ||
| Q3 25 | $50.9M | $202.5M | ||
| Q2 25 | $37.1M | $176.3M | ||
| Q1 25 | $30.7M | $127.1M | ||
| Q4 24 | $37.1M | $174.0M | ||
| Q3 24 | $37.3M | $150.6M | ||
| Q2 24 | $29.4M | $480.7M | ||
| Q1 24 | $32.1M | $112.3M |
总债务DCORARE
| Q4 25 | $298.8M | — | ||
| Q3 25 | $215.0M | — | ||
| Q2 25 | $218.1M | — | ||
| Q1 25 | $229.9M | — | ||
| Q4 24 | $229.8M | — | ||
| Q3 24 | $246.0M | — | ||
| Q2 24 | $250.9M | — | ||
| Q1 24 | $253.9M | — |
股东权益DCORARE
| Q4 25 | $662.1M | $-80.0M | ||
| Q3 25 | $649.0M | $9.2M | ||
| Q2 25 | $707.8M | $151.3M | ||
| Q1 25 | $693.0M | $144.2M | ||
| Q4 24 | $682.5M | $255.0M | ||
| Q3 24 | $665.6M | $346.8M | ||
| Q2 24 | $655.9M | $432.4M | ||
| Q1 24 | $645.5M | $140.3M |
总资产DCORARE
| Q4 25 | $1.2B | $1.5B | ||
| Q3 25 | $1.2B | $1.2B | ||
| Q2 25 | $1.1B | $1.3B | ||
| Q1 25 | $1.1B | $1.3B | ||
| Q4 24 | $1.1B | $1.5B | ||
| Q3 24 | $1.1B | $1.5B | ||
| Q2 24 | $1.1B | $1.6B | ||
| Q1 24 | $1.1B | $1.3B |
负债/权益比DCORARE
| Q4 25 | 0.45× | — | ||
| Q3 25 | 0.33× | — | ||
| Q2 25 | 0.31× | — | ||
| Q1 25 | 0.33× | — | ||
| Q4 24 | 0.34× | — | ||
| Q3 24 | 0.37× | — | ||
| Q2 24 | 0.38× | — | ||
| Q1 24 | 0.39× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-74.7M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $-78.8M | $-100.8M |
| 自由现金流率自由现金流/营收 | -36.5% | -48.6% |
| 资本支出强度资本支出/营收 | 1.9% | 0.5% |
| 现金转化率经营现金流/净利润 | -10.03× | — |
| 过去12个月自由现金流最近4个季度 | $-48.6M | $-472.0M |
8季度趋势，按日历期对齐
经营现金流DCORARE
| Q4 25 | $-74.7M | $-99.8M | ||
| Q3 25 | $18.1M | $-91.4M | ||
| Q2 25 | $22.4M | $-108.3M | ||
| Q1 25 | $771.0K | $-166.5M | ||
| Q4 24 | $18.4M | $-79.3M | ||
| Q3 24 | $13.9M | $-67.0M | ||
| Q2 24 | $3.5M | $-77.0M | ||
| Q1 24 | $-1.6M | $-190.7M |
自由现金流DCORARE
| Q4 25 | $-78.8M | $-100.8M | ||
| Q3 25 | $16.0M | $-92.7M | ||
| Q2 25 | $18.1M | $-110.7M | ||
| Q1 25 | $-4.0M | $-167.8M | ||
| Q4 24 | $14.6M | $-79.5M | ||
| Q3 24 | $12.0M | $-68.6M | ||
| Q2 24 | $144.0K | $-79.0M | ||
| Q1 24 | $-6.6M | $-193.9M |
自由现金流率DCORARE
| Q4 25 | -36.5% | -48.6% | ||
| Q3 25 | 7.5% | -58.0% | ||
| Q2 25 | 9.0% | -66.5% | ||
| Q1 25 | -2.1% | -120.5% | ||
| Q4 24 | 7.4% | -48.3% | ||
| Q3 24 | 5.9% | -49.2% | ||
| Q2 24 | 0.1% | -53.7% | ||
| Q1 24 | -3.5% | -178.2% |
资本支出强度DCORARE
| Q4 25 | 1.9% | 0.5% | ||
| Q3 25 | 1.0% | 0.8% | ||
| Q2 25 | 2.1% | 1.5% | ||
| Q1 25 | 2.5% | 1.0% | ||
| Q4 24 | 2.0% | 0.1% | ||
| Q3 24 | 1.0% | 1.2% | ||
| Q2 24 | 1.7% | 1.4% | ||
| Q1 24 | 2.6% | 3.0% |
现金转化率DCORARE
| Q4 25 | -10.03× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.79× | — | ||
| Q1 25 | 0.07× | — | ||
| Q4 24 | 2.72× | — | ||
| Q3 24 | 1.37× | — | ||
| Q2 24 | 0.45× | — | ||
| Q1 24 | -0.24× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DCO
| Other | $90.1M | 42% |
| Militaryand Space | $60.0M | 28% |
| Electronic Systems Segment | $31.3M | 15% |
| Commercial Aerospace | $24.8M | 11% |
| Estimate At Completion Adjustment | $6.6M | 3% |
| Industrial | $3.0M | 1% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
